Showing 1 to 2 of 2 results


GPT-5: Initial Hype Meets Reality Check
OpenAI's GPT-5, launched recently, initially showed promise with improved model selection and reduced hallucinations, but faced immediate criticism for producing shorter, inferior responses compared to previous models, raising questions about the scalability principle in AI development and the indus...
GPT-5: Initial Hype Meets Reality Check
OpenAI's GPT-5, launched recently, initially showed promise with improved model selection and reduced hallucinations, but faced immediate criticism for producing shorter, inferior responses compared to previous models, raising questions about the scalability principle in AI development and the indus...
Progress
48% Bias Score

AI Revolutionizes Drug Discovery: Lila Sciences and Recursion Pharmaceuticals Lead the Way
Lila Sciences and Recursion Pharmaceuticals are using AI to accelerate drug discovery, employing three scaling laws (pre-training, post-training, and test-time scaling) to analyze vast datasets and automate experimentation, potentially leading to breakthroughs in medicine and materials science.

AI Revolutionizes Drug Discovery: Lila Sciences and Recursion Pharmaceuticals Lead the Way
Lila Sciences and Recursion Pharmaceuticals are using AI to accelerate drug discovery, employing three scaling laws (pre-training, post-training, and test-time scaling) to analyze vast datasets and automate experimentation, potentially leading to breakthroughs in medicine and materials science.
Progress
24% Bias Score
Showing 1 to 2 of 2 results